Related content

The treatment of dysthymia with sertraline: a double-blind placebo-controlled trial in dysthymic outpatients without major depression

By Guelfi J.D.   Wiseman R.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 289-290

Elsevier

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial

By McClernon F.   Hiott F.   Westman Eric   Rose Jed   Levin Edward  

Psychopharmacology, Vol. 189, Iss. 1, 2006-11 ,pp. : 125-133

Springer Publishing Company

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Trial

By Lu Yang   Xiao Zhanqin  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 221-229

Adis International

Access to resources Recommend Favorite